Oncology Medicines Procurement
Indian Army · Pharmaceuticals · open
Key facts
- EMD: ₹9K
- Published: 03 Jun 2026
- Closing date: 17 Jun 2026
- Status: open
- Ministry: Ministry of Defence
- Department: Department of Military Affairs
- Office: Command Hospital Chandimandir
Description
Procurement of various oncology medicines including Crizotinib, Amivantamab, Bevacizumab, and others for the Indian Army.
Eligibility & requirements
- Experience required: 3 years
- Past performance: 50%
- Startup relaxation: Yes
- MSE relaxation: Yes
- Documents required: Experience Criteria, Past Performance, Bidder Turnover, Certificate (Requested in ATC), OEM Authorization Certificate, OEM Annual Turnover, Compliance of BoQ
Commercial terms
- Bid type: Two Packet Bid
- Evaluation: Item wise evaluation
- Make in India (MII): Yes
- MSE preference: Yes
Line items (1)
- Brentuximab vedotin 50mg per ml Inj — Qty: 1665 ml
1 tender document(s) available — sign up to download.